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Pain is one of the cardinal symptom in tumor patient, especially in Central Nervous System (CNS)                                     
tumor. It often impacts patient’s quality of life. The incidence and characteristic of pain have rarely 
been reported in Palembang, Indonesia. This observational study was planned to investigate the 
clinical presentation and epidemiology of CNS tumor firstly diagnosed in ward throughout July to 
December 2018. 99 patients recently diagnosed with CNS tumor were enrolled. From 99 patients, we 
found 34 patients with tumor associated pain. We further evaluated the information of pain linked with 
brain tumors via questionnaire and medical record. Of all 34 subjects, the age ranged from 43 to 79 
years old with female : male ratio 3:1. Pain was present 100% in spinal tumor and 54% in brain tumor. 
Clinical characteristics of pain found in brain tumor were typically in ipsilateral lesion (92%), 
pulsating (76%), moderate intensity (60%), recurrent (84%), not radiating (80%), with frequency of 3-
4 times in a week (48%). On the other hand, pain in spinal tumor was generally felt on the site of the 
lesion (100%), radiating (77.8%), electrical type of pain (44.4%), high intensity (77.8), and constant 
(88.9%). From this study we conclude that tumor locations can show some different pain 
characteristics. Therefore careful pain assessment is compulsory to have better understanding and 
more appropriate management. 
 





Pain is inevitably a part of benign and 
malignant tumor. This phenomenon has 
become a concern by the World Health 
Organization. It is known that 52 – 77% 
tumor patients has pain symptom and 1/3 
of them suffered at least moderate pain.1,2 
International Association For Study of 
Pain (IASP) states that every year, more 
than ten million persons in the world 
which has been diagnosed with malignant 
tumor experience pain as one of serious 
condition. This pain could be a result from 
complex mechanism which include an 
inflammatory process, ischemic, and 
compression of various structures.3 Pain 
prevalence has been increasing in 
developing country caused by delayed 
diagnosing and limited access of opioid. 
Study from WHO shows that more than 
80% of world population not acquire 
adequate pain treatment. Other study 
shows that inadequate pain management 
will significantly decrease patients quality 
of life.4 Therefore, pain needs 
multidimentional assessment and 
multidiscipline management.5 Study about 
CNS tumor associated pain has still rarely 
been reported. The data about pain profile 
such as location, characteristic, intensity, 
relieving, aggravating, and referred pain 
could be a helpful reference that leads to a 
better management. 





This is a descriptive study which collects 
the data from medical record and through 
questionnaire from hospitalized patient 
with CNS tumor associated pain in 
Mohammad Hoesin General Hospital 
Palembang from July to December 2018 
using total sampling technique. All 
patients with CNS tumor associated pain in 
hospital ward from July until December 
2018 were included and then excluded the 
ones with unconsciousness, aphasia, and 
previously receiving chemotherapy, 
radiation, and/or operation. All the data 





From July to December 2018 there were 
99 subjects (Table 1). Of all 99 subjects, 
90 patients have brain tumor and 9 patients 
have spinal tumor. From the brain tumor 
cases, 46 subjects were excluded due to 
aphasia and unconsciousness. In the end, 
we have 44 subjects with brain tumor, but 
only 25 suffered from pain, while on spinal 




Clinical distribution of patients with central nervous system tumor associated pain. 
 Brain tumor Spinal tumor  
  ±SD        n%  ±SD        n% 
Pain 25 56.8 9 100 
Without pain 19 43 0 0 
Total 44 100 9 100 
 
From our study we found the range age 
was 20-69 years with the percentage of 
woman and man were 76.5% and 23.5%. 
In brain and spinal tumor, the prevalence 
in woman was higher than man (76% and 
24%) and (77.8% and 22.2%). These 
results are listed in Table 2. 
 
Table 2 
Socio-demographic distribution of patients with central nervous system tumor associated pain. 
 
Based on table 3, subjects with CNS tumor 
were 73.5% brain tumor and 26.5% spinal 
tumor. We encountered 76% subjects with 
primary brain tumor and 24% subjects 
were secondary tumor. While on spinal 
 
 
Central nervous system tumor 
 ±SD        n% 
Age   
 <45 years 25 56.8 
 45-64 years 19 55.8 
 65-79 years 1 0.1 
 ≥80 years 0 0 
Sex   
 Male 8 23.5 
 Female  26 76.5 
Education   
 Primary school 12 35.3 
 >Middle  school 22 64.7 
Occupation   
 Working 8 33.5 
 Not working 26 76.5 




tumor, there were 33.3% cases of primary tumor and the rest 66.7% 
were secondary tumor. From this study, 
location of tumor was known to be linked 
to pain location and only 2 subjects had 
different pain location from the tumor. 
Patients with brain tumor mostly had 
recurrent pain (84%), intermittent (48%), 
moderate intensity (50%), and have equal 
percentage for relieving factor.  While in 
spinal tumor mostly have a constant pain 
(88.9%), severe pain intensity (77.8%), 
doesn’t have relieving pain (66.7%), and 
radiating pain (77.8%). 
 
Table 3 
Characteristic of pain associated to central nervous system tumor. 
 
Brain tumor Spinal tumor 
 ±SD        n%  ±SD        n% 
Tumor type     
 Primary 19 76 3 33.3 
 Secondary 6 24 6 66.7 
Location of pain     
 On site of the lesion 23 92 100 100 
 Away from the lesion site 2 8 0 0 
Pattern      
 Recurrent 21 84 1 11.1 
 Intermittent 4 16 8 88.9 
Frequency     
 Occasionally  
(1-2 days/week) 
6 24 0 0 
 Intermittent 
(3-4 days/week) 
12 48 1 11.1 
 Frequent  
(5 days/week) 
1 4 0 0 
 Constant  
(6-7 days/week) 
6 24 8 88.9 
Characteristic     
 Pulsating 19 76 0 0 
 Stabbing  1 4 2 22.2 
 Dull 2 8 1 11.1 
 Burning 0 0 0 0 
 Tightening 2 8 2 22.2 
 Electrical 1 4 4 44.4 
Intensity     
 Severe (7-10) 4 24 7 77.8 
 Moderate (4-6) 15 60 2 22.2 
 Mild (1-3) 6 24 0 0 
Aggravating factor     
 Yes 11 44 6 66.7 
 No 14 56 3 33.3 
Relieving factor     
  Yes 14 56 3 33.3 
  No 11 34 6 66.7 
Radiating     
 Yes 5 20 7 77.8 
 No 20 80 2 22.2 
 
 





Headache in patient with brain tumor is 
not always present. But, it has to be at least 
one or more neurological symptom to 
show a structural lesion on the brain. 
Purdy et al reported that approximately 
75% patients have pain related to brain 
tumor and 25% patients with no pain.6 
Benign tumor has a slow growth of tumor 
and mostly comes without pain.. From our 
study, we found that all of spinal tumor 
patients have pain related to tumor. 
Compression of spinal cord followed by 
destruction in periosteum are considered to 
be the main pathophysiology of pain on 
this case. Vischa et al and Lisa et al 
mentioned that pain is the most common 
symptom in spinal tumor with the 
prevalence almost 90%.7  
CNS tumor incidence increases with age 
because of the cumulative effect from 
carcinogenic exposure. Suggested main 
mechanism of this is because systemic 
inflammation increases with age.8,9 This 
increased sensitivity can generate chronic 
inflammation that leads to sensitisation of 
central and peripheral nociceptor. 
Anatomical changes in elderly are 
responsible for somatic sensation, 
expression receptor disturbances, and 
neurotransmitter. Another variable that can 
increase pain sensation is gender aspect. 
Various psychosocial mechanisms also 
play an important role that set different 
pain threshold in woman and man. Man 
tends to use a distraction to manage the 
pain, while woman tends to use the 
emotional aspects. The estrogen related 
mechanism also influences the severity of 
pain.11 
The pathogenesis of pain related to brain 
tumor include the traction process in 
vascular, cranial, compression of cervical 
nerve, peripheral sensitisation process with 
neurogenic inflammation, and central 
sensitisation through trigeminovascular 
afferent in meninges and cranial blood 
vessel.14 The pain is mostly described with 
pulsating pain. The underlying mechanism 
is the involvement of trigeminovascular 
system. This system consists of neuron 
that innervate the cerebral blood vessel. If 
there is any compression to the nerve, it 
will activate this system in meninges along 
with vasoactive neuropeptide release such 
as neurokinin A, substance P, and 
Calcitonin Gene Related Peptide by the 
afferent of trigeminal nerve. All this 
inflammation process in blood vessel then 
induces pulsating pain.6 
Almost all of brain tumor give the same 
location with the pain. Traction of tumor 
that compresses the pain sensitive 
structures is the leading cause. Malignant 
tumor usually presents a nonspecific and 
unlocalized pain because of high 
intracranial pressure and edema.15 In this 
study, only 2 patients show different 
location between pain and the site of 
tumor. The first patient is the metastasis 
tumor and the other one has 
hydrocephalus. On the other hand, spinal 
tumor has a localized pain that radiates 
based on the segment of dermatome. It is 
known to be radicular pain.16 This pain is 
caused by irritation of sensory or dorsal 
root ganglion on spinal nerve so it can 
generate pain along the dermatome. This 
pain can radiate to the leg or develop a 
tightening pain. There are various 
mechanisms that can cause pain in spinal 
tumor, such as pressure to periosteum, 
expansion inside the vertebra body, 
fracture, and invasion to paravertebral 
structure which can compress spinal nerve 
roots. Pain on this tumor mostly gives a 
constant and severe pain. This mechanism 
also leads to an intermittent and constant 




There are two locations of CNS tumor. 
From this study, different tumor location 
shows different characteristic of pain. This 
finding might become a guidance for 
clinicians to understand the characteristic 
of pain related to tumor based on the 




location so the management could be more 
adequate. However, larger sample and 
area are needed to provide more accurate 
and representative result. 
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